Analyst Consensus ?
ConsensusBuy44 ratings
Bullish3988.6%
Neutral511.4%
Bearish00.0%
FN2 Earnings Intelligence
Boston Scientific Corporation complete analyst coverage
Boston Scientific Corporation (BSX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$46.53Current
$48Low
$79.46Average
$130High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Jul 27, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 16, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Needham | Buy | Buy | Maintain | Jul 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Stifel | Buy | Buy | Maintain | Jun 25, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 24, 2026 |
| BTIG | Buy | Buy | Maintain | Jun 16, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Jun 1, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | May 29, 2026 |
| Wells Fargo | Equal Weight | Overweight | Downgrade | May 28, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | May 28, 2026 |
| Citigroup | Buy | Buy | Maintain | May 28, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 28, 2026 |
| Baird | Outperform | Outperform | Maintain | May 19, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 18, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 23, 2026 |
| Raymond James | Outperform | Strong Buy | Downgrade | Mar 30, 2026 |
| UBS | Buy | Buy | Maintain | Mar 17, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 5, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Feb 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 3, 2025 |
| Bernstein | Outperform | Outperform | Maintain | Oct 24, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 25, 2024 |
| Argus Research | Buy | Buy | Maintain | May 28, 2024 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Apr 28, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 28, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 23, 2020 |
| Stephens & Co. | Overweight | Overweight | Maintain | Mar 26, 2020 |
| CFRA | Strong Buy | Buy | Upgrade | Mar 9, 2020 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 30, 2019 |
| Argus | Buy | Buy | Maintain | Oct 26, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Apr 26, 2018 |
| Bank of America | Buy | Buy | Maintain | Apr 5, 2018 |
| BTIG Research | Buy | Neutral | Upgrade | Nov 30, 2017 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 27, 2017 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 24, 2015 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 4, 2015 |
| Benchmark | Buy | Hold | Upgrade | Oct 22, 2014 |
| PiperJaffray | Overweight | Neutral | Upgrade | Jan 21, 2014 |
| CL King | Neutral | Strong Buy | Downgrade | Sep 10, 2013 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jun 28, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $46.53. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $74 | $45.51 | +59.0% | Jul 28, 2026 |
| Oppenheimer | Analyst unavailable | $85 | $45.88 | +82.7% | Jul 27, 2026 |
| Truist Financial | Analyst unavailable | $62 | $44.6 | +33.2% | Jul 16, 2026 |
| Mizuho Securities | Anthony Petrone | $70 | $42.63 | +50.4% | Jul 15, 2026 |
| RBC Capital | Shagun Singh | $85 | $44.72 | +82.7% | Jul 13, 2026 |
| Needham | Mike Matson | $57 | $45.3 | +22.5% | Jul 8, 2026 |
| Evercore ISI | Analyst unavailable | $65 | $44.55 | +39.7% | Jul 6, 2026 |
| Stifel Nicolaus | Analyst unavailable | $65 | $44.46 | +39.7% | Jun 25, 2026 |
| Piper Sandler | Analyst unavailable | $65 | $47.17 | +39.7% | Jun 12, 2026 |
| Truist Financial | Analyst unavailable | $64 | $49.34 | +37.5% | Jun 4, 2026 |
| BTIG | Marie Thibault | $65 | $47.68 | +39.7% | Jun 2, 2026 |
| Canaccord Genuity | Analyst unavailable | $70 | $48.31 | +50.4% | Jun 1, 2026 |
| Goldman Sachs | Analyst unavailable | $71 | $50.46 | +52.6% | May 28, 2026 |
| Robert W. Baird | Analyst unavailable | $70 | $50.46 | +50.4% | May 28, 2026 |
| Leerink Partners | Mike Kratky | $74 | $50.46 | +59.0% | May 28, 2026 |
| Barclays | Analyst unavailable | $89 | $50.46 | +91.3% | May 28, 2026 |
| Wells Fargo | Larry Biegelsen | $55 | $50.46 | +18.2% | May 28, 2026 |
| Stifel Nicolaus | Rick Wise | $75 | $51.07 | +61.2% | May 27, 2026 |
| Robert W. Baird | Analyst unavailable | $75 | $55.92 | +61.2% | May 19, 2026 |
| Daiwa | Analyst unavailable | $60 | $58.45 | +28.9% | Apr 29, 2026 |
| RBC Capital | Analyst unavailable | $100 | $65.8 | +114.9% | Apr 23, 2026 |
| Oppenheimer | Analyst unavailable | $90 | $65.72 | +93.4% | Apr 23, 2026 |
| Canaccord Genuity | William Plovanic | $71 | $64.87 | +52.6% | Apr 23, 2026 |
| Needham | Mike Matson | $77 | $64.87 | +65.5% | Apr 23, 2026 |
| Truist Financial | Analyst unavailable | $85 | $64.87 | +82.7% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $78 | $64.87 | +67.6% | Apr 23, 2026 |
| Wells Fargo | Analyst unavailable | $75 | $64.87 | +61.2% | Apr 23, 2026 |
| Barclays | Matt Miksic | $96 | $64.87 | +106.3% | Apr 23, 2026 |
| Goldman Sachs | David Roman | $84 | $64.87 | +80.5% | Apr 22, 2026 |
| Jefferies | Matthew Taylor | $100 | $64.87 | +114.9% | Apr 22, 2026 |
| Stifel Nicolaus | Rick Wise | $85 | $60.99 | +82.7% | Apr 21, 2026 |
| Truist Financial | Analyst unavailable | $90 | $64.92 | +93.4% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $90 | $62.06 | +93.4% | Apr 13, 2026 |
| Goldman Sachs | Analyst unavailable | $93 | $70.17 | +99.9% | Mar 26, 2026 |
| Canaccord Genuity | William Plovanic | $109 | $74.73 | +134.3% | Feb 17, 2026 |
| Bernstein | Lee Hambright | $112 | $77.46 | +140.7% | Feb 6, 2026 |
| Truist Financial | Analyst unavailable | $95 | $77.02 | +104.2% | Feb 5, 2026 |
| RBC Capital | Analyst unavailable | $115 | $77.16 | +147.2% | Feb 5, 2026 |
| Needham | Analyst unavailable | $97 | $75.52 | +108.5% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $115 | $75.29 | +147.2% | Feb 5, 2026 |
| Evercore ISI | Analyst unavailable | $96 | $75.64 | +106.3% | Feb 5, 2026 |
| Wells Fargo | Analyst unavailable | $94 | $75.5 | +102.0% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $99 | $75.5 | +112.8% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $101 | $75.5 | +117.1% | Feb 5, 2026 |
| UBS | Analyst unavailable | $120 | $75.5 | +157.9% | Feb 5, 2026 |
| Canaccord Genuity | William Plovanic | $112 | $75.5 | +140.7% | Feb 5, 2026 |
| Stifel Nicolaus | Rick Wise | $110 | $75.5 | +136.4% | Feb 4, 2026 |
| BTIG | Analyst unavailable | $110 | $75.61 | +136.4% | Feb 4, 2026 |
| Barclays | Analyst unavailable | $124 | $91.87 | +166.5% | Feb 3, 2026 |
| National Bank | Analyst unavailable | $115 | $93.13 | +147.2% | Feb 2, 2026 |
| Oppenheimer | Analyst unavailable | $100 | $90.03 | +114.9% | Jan 16, 2026 |
| Goldman Sachs | David Roman | $112 | $98.38 | +140.7% | Jan 9, 2026 |
| Evercore ISI | Analyst unavailable | $112 | $95.15 | +140.7% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $120 | $96.56 | +157.9% | Dec 18, 2025 |
| RBC Capital | Analyst unavailable | $130 | $92.95 | +179.4% | Dec 17, 2025 |
| Canaccord Genuity | William Plovanic | $131 | $92.95 | +181.5% | Dec 17, 2025 |
| Truist Financial | Analyst unavailable | $130 | $103.52 | +179.4% | Oct 23, 2025 |
| Morgan Stanley | Patrick Wood | $130 | $103.85 | +179.4% | Oct 23, 2025 |
| UBS | Analyst unavailable | $140 | $104.24 | +200.9% | Oct 23, 2025 |
| Wells Fargo | Analyst unavailable | $125 | $104.24 | +168.6% | Oct 23, 2025 |
| Goldman Sachs | Analyst unavailable | $124 | $103.85 | +166.5% | Oct 22, 2025 |
| Evercore ISI | Analyst unavailable | $110 | $96.7 | +136.4% | Oct 7, 2025 |
| Barclays | Analyst unavailable | $136 | $95.85 | +192.3% | Oct 2, 2025 |
| Truist Financial | Richard Newitter | $129 | $94.15 | +177.2% | Oct 1, 2025 |
| BTIG | Analyst unavailable | $132 | $97.63 | +183.7% | Oct 1, 2025 |
| Robert W. Baird | Analyst unavailable | $128 | $97.63 | +175.1% | Oct 1, 2025 |
| Canaccord Genuity | Analyst unavailable | $132 | $97.63 | +183.7% | Oct 1, 2025 |
| Oppenheimer | Suraj Kalia | $125 | $108.14 | +168.6% | Sep 8, 2025 |
| Raymond James | Jayson Bedford | $121 | $103.8 | +160.0% | Jul 21, 2025 |
| Leerink Partners | Mike Kratky | $118 | $101.49 | +153.6% | Jun 16, 2025 |
| Truist Financial | Richard Newitter | $117 | $100.55 | +151.5% | Apr 24, 2025 |
| BTIG | Marie Thibault | $124 | $98.87 | +166.5% | Apr 23, 2025 |
| Argus Research | Analyst unavailable | $130 | $105.35 | +179.4% | Feb 18, 2025 |
| Piper Sandler | Matt O'Brien | $115 | $103.07 | +147.2% | Feb 3, 2025 |
| Evercore ISI | Vijay Kumar | $100 | $89.38 | +114.9% | Jan 2, 2025 |
| BTIG | Marie Thibault | $101 | $89.68 | +117.1% | Dec 30, 2024 |
| RBC Capital | Shagun Singh | $98 | $87.45 | +110.6% | Oct 24, 2024 |
| C.L. King | Kristen Stewart | $90 | $87.45 | +93.4% | Oct 24, 2024 |
| Canaccord Genuity | William Plovanic | $98 | $88.07 | +110.6% | Oct 21, 2024 |
| Stifel Nicolaus | Rick Wise | $100 | $86.42 | +114.9% | Oct 18, 2024 |
| Robert W. Baird | David Rescott | $100 | $87.55 | +114.9% | Oct 15, 2024 |
| Truist Financial | Richard Newitter | $100 | $87.2 | +114.9% | Oct 14, 2024 |
| Piper Sandler | Matt O'Brien | $90 | $84.22 | +93.4% | Sep 19, 2024 |
| Deutsche Bank | Pito Chickering | $78 | $78.11 | +67.6% | Jul 25, 2024 |
| BTIG | Marie Thibault | $84 | $77.69 | +80.5% | Jul 15, 2024 |
| Canaccord Genuity | William Plovanic | $83 | $76.31 | +78.4% | Jun 18, 2024 |
| Robert W. Baird | David Rescott | $90 | $77.42 | +93.4% | Jun 11, 2024 |
| Goldman Sachs | David Roman | $90 | $74.98 | +93.4% | May 30, 2024 |
| Argus Research | John Eade | $95 | $75.63 | +104.2% | May 28, 2024 |
| Oppenheimer | Steven Lichtman | $77 | $73.27 | +65.5% | Apr 25, 2024 |
| Evercore ISI | Vijay Kumar | $78 | $72.91 | +67.6% | Apr 25, 2024 |
| RBC Capital | Shagun Singh | $82 | $72.91 | +76.2% | Apr 25, 2024 |
| Mizuho Securities | Anthony Petrone | $85 | $72.91 | +82.7% | Apr 25, 2024 |
| Robert W. Baird | David Rescott | $84 | $72.91 | +80.5% | Apr 25, 2024 |
| Truist Financial | Richard Newitter | $86 | $72.91 | +84.8% | Apr 25, 2024 |
| Wells Fargo | Lawrence Biegelsen | $82 | $72.91 | +76.2% | Apr 25, 2024 |
| Deutsche Bank | Pito Chickering | $73 | $72.91 | +56.9% | Apr 24, 2024 |
| BTIG | Marie Thibault | $80 | $72.91 | +71.9% | Apr 24, 2024 |
| Stifel Nicolaus | Rick Wise | $83 | $72.91 | +78.4% | Apr 24, 2024 |
| BTIG | Marie Thibault | $74 | $68.07 | +59.0% | Apr 15, 2024 |
| Argus Research | John Eade | $80 | $67.45 | +71.9% | Apr 3, 2024 |
| Mizuho Securities | Anthony Petrone | $80 | $64.82 | +71.9% | Feb 1, 2024 |
| J.P. Morgan | Analyst unavailable | $55 | $47.31 | +18.2% | Feb 2, 2023 |
| Needham | Analyst unavailable | $53 | $47.54 | +13.9% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $56 | $46.18 | +20.4% | Jan 6, 2023 |
| Mizuho Securities | Anthony Petrone | $52 | $46.08 | +11.8% | Dec 22, 2022 |
| Truist Financial | Analyst unavailable | $54 | $45.64 | +16.1% | Dec 20, 2022 |
| Raymond James | Analyst unavailable | $54 | $45.63 | +16.1% | Dec 8, 2022 |
| Raymond James | Analyst unavailable | $48 | $40.83 | +3.2% | Jul 28, 2022 |
| BTIG | Analyst unavailable | $50 | $40.31 | +7.5% | Jul 28, 2022 |
| Truist Financial | Analyst unavailable | $45 | $37.44 | -3.3% | Jul 20, 2022 |
| Canaccord Genuity | Analyst unavailable | $43 | $37.76 | -7.6% | Jun 29, 2022 |
| BTIG | Analyst unavailable | $45 | $37.1 | -3.3% | Jun 24, 2022 |
| Piper Sandler | Matt O’Brien | $50 | $42.11 | +7.5% | Apr 30, 2022 |
| Raymond James | Analyst unavailable | $50 | $43 | +7.5% | Apr 28, 2022 |
| Leerink Partners | Analyst unavailable | $48 | $43.06 | +3.2% | Apr 28, 2022 |
| Bank of America Securities | Travis Steed | $55 | $43.96 | +18.2% | Mar 3, 2022 |
| Cowen & Co. | Josh Jennings | $50 | $41.44 | +7.5% | Feb 2, 2022 |
| BTIG | Marie Thibault | $52 | $41.44 | +11.8% | Feb 2, 2022 |
| Macquarie | Luke McFarlane | $51 | $41.28 | +9.6% | Dec 9, 2021 |
| Canaccord Genuity | William Plovanic | $51 | $43.24 | +9.6% | Oct 28, 2021 |
| UBS | Brent Dilts | $118 | $43.24 | +153.6% | Oct 28, 2021 |
| Piper Sandler | Matthew O'Brien | $51 | $43.73 | +9.6% | Oct 27, 2021 |
| Credit Suisse | Matt Miksic | $54 | $45 | +16.1% | Sep 23, 2021 |
| Jefferies | Anthony Petrone | $55 | $44.31 | +18.2% | Sep 22, 2021 |
| Argus Research | John Eade | $132 | $45.88 | +183.7% | Aug 2, 2021 |
| Wells Fargo | Larry Biegelsen | $52.5 | $45.88 | +12.8% | Aug 1, 2021 |
| Stifel Nicolaus | Rick Wise | $50 | $45.51 | +7.5% | Jul 27, 2021 |
| Goldman Sachs | Amit Hazan | $50 | $42.74 | +7.5% | Jul 14, 2021 |
| Stephens | Chris Cooley | $52 | $44.1 | +11.8% | Apr 29, 2021 |
| Oppenheimer | Steven Lichtman | $47 | $44.24 | +1.0% | Apr 28, 2021 |
| Citigroup | Joanne Wuensch | $51 | $44.24 | +9.6% | Apr 28, 2021 |
Track every rating change on BSX the moment it posts. Free to start.
Start free